Latest News about BBIO
Recent news which mentions BBIO
From Benzinga
BridgeBio Shares Plunge After it Details Out-Licensing Plans For 'Restructuring Initiative'
May 05, 2022
Tickers
BBIO
From Benzinga
BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy Trial
April 04, 2022
Tickers
BBIO
From Benzinga
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
March 14, 2022
Tickers
BBIO
From Benzinga
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
From Benzinga
3 Can't-Miss Biotech Events Coming Up in 2022
January 07, 2022
From Motley Fool
BZ Chart Of The Day: BridgeBio Pharma Teaches Traders Harsh Lesson
January 05, 2022
Tickers
BBIO
From Benzinga
40 Biggest Movers From Friday
January 03, 2022
From Benzinga
The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 31, 2021
From Benzinga
21 Stocks Moving In Friday's Mid-Day Session
December 31, 2021
From Benzinga
3 Stocks Insiders Are Buying
December 31, 2021
From Benzinga
Is BridgeBio Pharma Stock a Buy on the Dip?
December 29, 2021
From Motley Fool
45 Biggest Movers From Yesterday
December 29, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 28, 2021
From Benzinga
25 Stocks Moving In Tuesday's Mid-Day Session
December 28, 2021
From Benzinga
10 Biggest Price Target Changes For Tuesday
December 28, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 28, 2021
From Benzinga
51 Biggest Movers From Yesterday
December 28, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.